“Genomics can reduce uncertainty about the translation of population evidence to individual patients in 3 ways. First, the development of genomically targeted therapies ties the treatment decision to the results of a test for a specific genetic alteration in an individual patient, reducing uncertainty about who should be treated. Second, pharmacogenomics enables prediction of drug response from information about variation in metabolizing enzymes….” Katrina Armstrong, MD, MS. JAMA. Published online November 8, 2012
